Your browser doesn't support javascript.
loading
Expression, Purification, and Characterization of Plasmodium vivax Lactate Dehydrogenase from Bacteria without Codon Optimization.
Kim, Yeon-Jun; Shin, Jun-Seop; Lee, Kang Woo; Eom, Hyo-Ji; Jo, Byung Gwan; Lee, Jin Woo; Kim, Jun Hyoung; Kim, So Yeon; Kang, Jung Hoon; Choi, Jae-Won.
Afiliação
  • Kim YJ; Department of Biomedical Science, Cheongju University, Cheongju 28160, Republic of Korea.
  • Shin JS; Department of Biomedical Science, Cheongju University, Cheongju 28160, Republic of Korea.
  • Lee KW; Department of Biomedical Science, Cheongju University, Cheongju 28160, Republic of Korea.
  • Eom HJ; Department of Biomedical Science, Cheongju University, Cheongju 28160, Republic of Korea.
  • Jo BG; Department of Biomedical Science, Cheongju University, Cheongju 28160, Republic of Korea.
  • Lee JW; College of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.
  • Kim JH; Division of Infectious Diseases, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju 28644, Republic of Korea.
  • Kim SY; Department of Dental Hygiene, Cheongju University, Cheongju 28503, Republic of Korea.
  • Kang JH; Department of Biomedical Science, Cheongju University, Cheongju 28160, Republic of Korea.
  • Choi JW; Department of Biopharmaceutical Sciences, Cheongju University, Cheongju 28160, Republic of Korea.
Int J Mol Sci ; 24(13)2023 Jul 04.
Article em En | MEDLINE | ID: mdl-37446261
ABSTRACT
Plasmodium vivax is the most widespread cause of malaria, especially in subtropical and temperate regions such as Asia-Pacific and America. P. vivax lactate dehydrogenase (PvLDH), an essential enzyme in the glycolytic pathway, is required for the development and reproduction of the parasite. Thus, LDH from these parasites has garnered attention as a diagnostic biomarker for malaria and as a potential molecular target for developing antimalarial drugs. In this study, we prepared a transformed Escherichia coli strain for the overexpression of PvLDH without codon optimization. We introduced this recombinant plasmid DNA prepared by insertion of the PvLDH gene in the pET-21a(+) expression vector, into the Rosetta(DE3), an E. coli strain suitable for eukaryotic protein expression. The time, temperature, and inducer concentration for PvLDH expression from this E. coli Rosetta(DE3), containing the original PvLDH gene, were optimized. We obtained PvLDH with a 31.0 mg/L yield and high purity (>95%) from this Rosetta(DE3) strain. The purified protein was characterized structurally and functionally. The PvLDH expressed and purified from transformed bacteria without codon optimization was successfully demonstrated to exhibit its potential tetramer structure and enzyme activity. These findings are expected to provide valuable insights for research on infectious diseases, metabolism, diagnostics, and therapeutics for malaria caused by P. vivax.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Vivax / Malária Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Vivax / Malária Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article